Greenberg Traurig is extremely proud to represent Redhill Biopharma with the recent announcement of providing an initial update on the compassionate use program with its investigational drug, opaganib, in patients
Continue Reading Greenberg Traurig Is Proud to Represent Redhill Biopharma Treating COVID-19 Patient with Opaganib in Israel Under Compassionate Use

san-francisco_image

Innovation and progress are core ingredients in today’s financial ecosystem, especially in the fields of health care and life sciences.  Greenberg Traurig has a renowned healthcare practice, serving many
Continue Reading GT Events during the 2016 JPMorgan Healthcare Conference & the 9th Annual OneMedForum in San Francisco